Stay updated on Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.3 to v3.5.4, signaling a new build deployment. This update does not modify the study content or essential information on the page.
    Difference
    0.1%
    Check dated 2026-05-15T04:59:11.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Version label updated from v3.5.2 to v3.5.3, signaling a new release of the page interface. The update does not modify the study content or data.
    Difference
    0.1%
    Check dated 2026-04-30T18:09:52.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:05:42.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision added: v3.5.0; revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T19:52:14.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be an internal version update with no changes to study content or eligibility.
    Difference
    0.1%
    Check dated 2026-03-11T17:57:20.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added to the page. The prior government funding/operating status notice (v3.4.1) has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T09:59:57.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.